Heme Oxygenase-1 microsatellite polymorphism and haplotypes are associated with the development of acute respiratory distress syndrome
- 13 June 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 35 (8), 1343-1351
- https://doi.org/10.1007/s00134-009-1504-6
Abstract
Heme oxygenase-1 (HO-1) acts in cytoprotection against acute lung injury. The polymorphic (GT)n repeat in the HO-1 gene (HMOX1) promoter regulates HMOX1 expression. We investigated the associations of HMOX1 polymorphisms with acute respiratory distress syndrome (ARDS) risk and plasma HO-1 levels. Unmatched, nested case–control study. Academic medical center. Consecutive patients with ARDS risk factors upon ICU admission were prospectively enrolled. Cases were 437 Caucasians who developed ARDS and controls were 1,014 Caucasians who did not. We genotyped the (GT)n polymorphism and three tagging single nucleotide polymorphisms (tSNPs) in 1,451 patients, and measured the plasma HO-1 levels in 106 ARDS patients. We clustered the (GT)n repeats into: S-allele (<24 repeats), M-allele (24–30 repeats) and L-allele (≥31 repeats). We found that longer (GT)n repeats were associated with reduced ARDS risk (P trend = 0.004 for both alleles and genotypes), but no individual tSNP was associated with ARDS risk. HMOX1 haplotypes were significantly associated with ARDS risk (global test, P = 0.016), and the haplotype S-TAG was associated with increased ARDS risk (OR, 1.75; 95% CI, 1.15–2.68; P = 0.010). Intermediate-phenotype analysis showed longer (GT)n repeats were associated with higher plasma HO-1 levels (P trend = 0.019 for alleles and 0.027 for genotypes). Longer (GT)n repeats in the HMOX1 promoter are associated with higher plasma HO-1 levels and reduced ARDS risk. The common haplotype S-TAG is associated with increased ARDS risk. Our results suggest that HMOX1 variation may modulate ARDS risk through the promoter microsatellite polymorphism.This publication has 40 references indexed in Scilit:
- Protective Functions of Heme Oxygenase-1 and Carbon Monoxide in the Respiratory SystemAntioxidants and Redox Signaling, 2007
- Arterial carboxyhemoglobin level and outcome in critically ill patients*Critical Care Medicine, 2007
- Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stentingEuropean Heart Journal, 2007
- Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter and Cardiac Allograft VasculopathyThe Journal of Heart and Lung Transplantation, 2005
- Microsatellite Polymorphism in the Heme Oxygenase-1 Gene Promoter Is Associated with Susceptibility to Cerebral Malaria in MyanmarJapanese Journal of Infectious Diseases, 2005
- Absence of heme oxygenase-1 expression in the lung parenchyma exacerbates endotoxin-induced acute lung injury and decreases surfactant protein-B levels.2005
- Heme Oxygenase-1American Journal of Respiratory and Critical Care Medicine, 2005
- Clinical predictors of and mortality in acute respiratory distress syndrome: Potential role of red cell transfusion*Critical Care Medicine, 2005
- Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemiaArthritis Research & Therapy, 2005
- Protective Effects of Heme Oxygenase-1 in Acute Lung InjurySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1999